Patient Guide: A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 119 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06131372
Status: COMPLETED
Condition: Chronic Kidney Disease, Type 2 Diabetes, Obesity
Phase: PHASE2

Find a Study Location Near You

This study is available at 119 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Concord, California
  • • Palm Springs, California
  • • San Dimas, California
  • • And 116 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo - Join Clinical Trial NCTNCT06131372

How to Join This Clinical Trial - NCTNCT06131372

Learn how to participate in this PHASE2 trial studying an investigational therapy for Chronic Kidney Disease, Type 2 Diabetes, Obesity. Current status: COMPLETED.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Kidney Disease, Type 2 Diabetes, Obesity. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Kidney Disease, Type 2 Diabetes, Obesity
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
COMPLETED
Study Identifier
NCTNCT06131372 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 119 locations. Find a study site near you:

Clinical Research Site

Concord, California 94520 - United States

Status: Contact for availability

Clinical Research Site

Palm Springs, California 91355 - United States

Status: Contact for availability

Clinical Research Site

San Dimas, California 91773 - United States

Status: Contact for availability

Clinical Research Site

San Ramon, California 94583 - United States

Status: Contact for availability

Clinical Research Site

Fleming Island, Florida 32003 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33130 - United States

Status: Contact for availability

Clinical Research Site

Orlando, Florida 32804 - United States

Status: Contact for availability

Clinical Research Site

Valparaiso, Indiana 46383 - United States

Status: Contact for availability

Clinical Research Site

Flint, Michigan 48532 - United States

Status: Contact for availability

Clinical Research Site

Omaha, Nebraska 68198 - United States

Status: Contact for availability

And 109 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Chronic Kidney Disease, Type 2 Diabetes, Obesity:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation